OEE Monitoring Solution for Pharmaceutical Manufacturing: Improve Production Efficiency and Equipment Performance

Pharmaceutical manufacturing requires precise production processes, reliable equipment, consistent product quality, and carefully controlled operating conditions. From raw material preparation and granulation to compression, coating, filling, packaging, and inspection, every production stage must operate according to defined procedures.

Maintaining efficient operations across these processes can be challenging. Equipment breakdowns, extended changeovers, unexpected stoppages, slower production cycles, and material-handling delays can affect manufacturing schedules and equipment utilisation.

At the same time, pharmaceutical manufacturers must maintain appropriate quality systems, documentation, and process controls. Production efficiency improvements cannot come at the expense of product quality, patient safety, or regulatory requirements.

For pharma operations managers, knowing the number of batches completed during a shift is not enough. They also need to understand how effectively production equipment is being used, where operating time is lost, and which factors are affecting output.

This is where Pharmaceutical OEE Monitoring becomes valuable. It helps manufacturers measure Overall Equipment Effectiveness (OEE) through availability, performance, and quality indicators.

With reliable machine and production information, pharmaceutical manufacturers can identify recurring equipment losses, improve production visibility, and make better operational decisions while maintaining their established quality and compliance processes.

What Is Pharmaceutical OEE Monitoring?

Pharmaceutical OEE Monitoring is the process of measuring the effectiveness of manufacturing equipment using availability, performance, and quality data.

OEE stands for Overall Equipment Effectiveness . It provides a structured way to understand how much of the planned production time is being converted into acceptable production output.

A pharmaceutical manufacturing facility may use different types of equipment, depending on its products and processes:

• Raw material dispensing systems

• Mixing and granulation equipment

• Fluid bed dryers

• Tablet compression machines

• Tablet coating machines

• Capsule filling machines

• Liquid filling equipment

• Sterilisation equipment

• Inspection and packaging machines

Each machine contributes to the manufacturing process. A delay or stoppage at one stage can affect the production schedule and the availability of equipment in subsequent stages.

OEE monitoring helps manufacturers evaluate machine-level performance rather than relying only on manually prepared production reports.

Depending on machine connectivity and system configuration, manufacturers may monitor:

• Machine running and stopped status

• Equipment operating time

• Production output and cycle counts

• Actual versus expected production rates

• Downtime duration and reasons

• Good and rejected output

• Shift-wise machine performance

• Availability, performance, and quality percentages

• Overall OEE

The specific data collected should be defined according to the equipment, manufacturing process, and applicable data-governance requirements.

OEE monitoring supports operational performance analysis. It does not replace validated manufacturing systems, batch records, quality controls, or regulatory documentation.

Why Pharmaceutical Manufacturers Need OEE Monitoring

Pharmaceutical production involves controlled processes, specialised equipment, and strict operating requirements. Even when equipment is technically available, production losses can occur because of interruptions, slow operating cycles, or process-related constraints.

Several challenges make OEE monitoring useful.

1. Unexpected Equipment Downtime

Pharmaceutical equipment may stop because of mechanical faults, electrical issues, sensor failures, utility interruptions, maintenance requirements, or other operational problems.

For example, an unexpected stoppage in a tablet compression machine can affect the planned production schedule and create delays in downstream activities.

If downtime is recorded only through manual reports, short interruptions may be missed or incorrectly classified.

OEE monitoring helps capture machine interruptions and analyse their frequency, duration, and operational impact.

2. Extended Changeover and Cleaning Activities

Pharmaceutical facilities may manufacture multiple products or batches using shared equipment.

Changing between production activities can involve equipment preparation, cleaning, inspection, setup, and other approved procedures.

These activities are essential to maintaining the required manufacturing controls, but they also influence equipment availability and production scheduling.

Tracking changeover and cleaning activities separately helps operations managers understand how much time is allocated to these tasks and identify opportunities to improve coordination without compromising established procedures.

3. Production Cycle-Time Variations

Different products and manufacturing processes may require different operating speeds and cycle times.

Actual production rates may vary because of equipment condition, process settings, material characteristics, or interruptions during operation.

Monitoring actual output against approved reference rates helps identify performance gaps and provides a starting point for further investigation.

4. Batch Production Delays

Pharmaceutical manufacturing frequently uses batch-based production.

A batch may pass through several stages, each requiring equipment, materials, and scheduled processing time.

Delays in one stage can affect the availability of resources for subsequent batches.

Production monitoring helps operations managers understand equipment utilisation and identify recurring delays that affect manufacturing schedules.

5. Limited Visibility Across Manufacturing Equipment

A pharmaceutical plant may operate multiple production areas with different machines, production schedules, and operating requirements.

When machine information is maintained in separate records, it becomes difficult to compare equipment performance and identify recurring production losses.

A centralised monitoring dashboard can provide a consolidated view of machine status, operating time, downtime, and production performance.

Understanding OEE in Pharmaceutical Manufacturing

OEE measures how effectively equipment uses its planned production time.

The standard formula is:

OEE = Availability × Performance × Quality

Each factor represents a different category of production loss.

1. Availability

Availability measures the percentage of planned production time during which the equipment was actually operating.

Availability = Operating Time ÷ Planned Production Time × 100

For example:

• Planned production time: 450 minutes

• Total downtime: 45 minutes

• Actual operating time: 405 minutes

Availability:

405 ÷ 450 × 100 = 90%

This means the equipment operated for 90% of its planned production time.

2. Performance

Performance measures how closely actual production matches the expected production rate.

Performance = Ideal Cycle Time × Total Units Produced ÷ Operating Time × 100

For example, consider a tablet production machine with:

• Ideal cycle time: 2 seconds per tablet

• Operating time: 405 minutes

• Actual production: 11,340 tablets

Expected output:

405 × 60 ÷ 2 = 12,150 tablets

Performance:

11,340 ÷ 12,150 × 100 = 93.33%

This indicates that the machine achieved approximately 93.33% of its expected production rate while operating.

For batch-based processes, manufacturers should use an appropriate and consistent production unit, such as kilograms, litres, tablets, capsules, or completed batches.

3. Quality

Quality measures the percentage of total production that meets the defined acceptance criteria.

Quality = Good Units ÷ Total Units Produced × 100

Suppose the machine produces 11,340 tablets, of which 11,113 meet the applicable quality requirements.

Quality:

11,113 ÷ 11,340 × 100 = 98% approximately

The remaining output represents quality losses under the defined OEE calculation rules.

In pharmaceutical manufacturing, the definition of good output must align with approved quality procedures. OEE calculations should not independently determine whether a batch or product is suitable for release.

4. Overall OEE Calculation

Using the example:

• Availability: 90%

• Performance: 93.33%

• Quality: 98%

OEE:

90% × 93.33% × 98% = 82.32% approximately

This provides a combined measure of equipment effectiveness based on the three OEE factors.

Actual pharmaceutical operations may require different calculation methods depending on whether equipment is used for continuous production, discrete units, or batch processing.

Manufacturers should define planned production time, reference cycle times, accepted output, and downtime classifications consistently before comparing OEE across machines or production areas.

Key Features of Pharmaceutical OEE Monitoring Software

An effective OEE monitoring solution should provide reliable production information and help operations teams identify equipment-related losses.

1. Real-Time Equipment Status Monitoring

Equipment status monitoring provides visibility into whether machines are running, stopped, or in another configured operating state.

A centralised dashboard can help managers review the operating status of production equipment across different manufacturing areas.

For example, supervisors may be able to identify whether a compression machine, filling machine, or packaging machine is currently operating or experiencing an interruption.

Internal link opportunity: Link the anchor text Machine Monitoring to the relevant Robato Systems product page in this section.

2. Automated Production Counting

Accurate production counting helps manufacturers compare actual output with planned production targets.

Depending on available machine signals, production data can be collected through supported controller interfaces, PLCs, sensors, or other integration methods.

The production unit should reflect the actual manufacturing process.

Examples include:

• Tablets produced

• Capsules filled

• Bottles filled

• Packages completed

• Kilograms of processed material

• Litres of manufactured product

For batch-based operations, the monitoring configuration should distinguish between machine activity, production cycles, and completed batch quantities.

Automated data collection can reduce manual recording effort, but any data used for regulated records must follow the facility's applicable validation, access-control, and documentation requirements.

3. Downtime Tracking and Analysis

Downtime tracking helps identify when equipment stops and how much planned production time is lost.

Pharmaceutical manufacturers can configure downtime categories according to their operations.

Common categories may include:

• Equipment breakdown

• Mechanical or electrical fault

• Changeover and setup

• Cleaning and inspection

• Material shortage

• Utility interruption

• Maintenance activity

• Production planning delay

• Equipment adjustment

Analysing downtime by reason helps managers identify recurring issues and prioritise maintenance or operational improvements.

4. Production Cycle-Time Monitoring

Cycle-time monitoring compares actual equipment performance with approved production reference values.

For example, a tablet compression machine may have a defined production rate for a particular product and operating configuration.

Monitoring actual output against that reference helps identify equipment that is consistently operating below expectations.

Reference rates should be maintained for the relevant product, process, and equipment configuration rather than applying one value to every production activity.

5. Centralised OEE Dashboard

A centralised dashboard provides a consolidated view of equipment and production performance.

Depending on the system configuration, managers may review:

• Availability percentage

• Performance percentage

• Quality percentage

• Overall OEE

• Equipment running status

• Production output

• Downtime duration

• Shift-wise performance

• Production target achievement

This helps operations managers identify underperforming equipment and review production conditions across different manufacturing areas.

6. Shift-Wise Production Reports

Pharmaceutical facilities may operate multiple shifts with different production schedules and equipment requirements.

Shift-wise reporting helps managers compare operating time, downtime, and production output across defined working periods.

These reports can support production reviews and shift handovers by providing a consistent view of equipment performance.

7. Historical Performance Analytics

Historical data helps manufacturers identify recurring equipment issues and understand long-term performance trends.

Managers can review downtime, machine utilisation, production rates, and OEE over selected periods.

This information can support maintenance planning, production scheduling, and continuous improvement initiatives.

Where OEE data is used alongside regulated manufacturing information, the applicable data-integrity and record-management requirements should be followed.

How OEE Monitoring Improves Pharmaceutical Manufacturing Efficiency

OEE monitoring creates value when production teams use reliable equipment data to identify losses and implement appropriate improvements.

Reduce Unplanned Equipment Downtime

Unexpected equipment stoppages reduce available production time and may delay scheduled manufacturing activities.

By reviewing downtime frequency, duration, and reason categories, maintenance and operations teams can identify recurring equipment problems.

For example, repeated stoppages on a packaging machine may require an investigation into sensors, mechanical components, material feeding, or equipment condition.

Improve Equipment Utilisation

Equipment utilisation improves when avoidable waiting time and interruptions are reduced.

Monitoring machine status and operating time helps managers understand how available equipment capacity is being used.

This information can support better coordination between production planning, maintenance, material handling, and other operational teams.

Improve Production Scheduling

Reliable equipment-performance information helps planners understand actual production capacity.

Historical cycle times, downtime trends, and machine availability can support more realistic manufacturing schedules and equipment allocation.

This is particularly useful when several products or batches share the same production equipment.

Identify Recurring Performance Losses

Comparing actual production output with approved reference rates helps identify equipment that consistently operates below expectations.

Teams can investigate whether the differences are related to equipment condition, process requirements, material characteristics, or operational interruptions.

Any improvement must be evaluated through the facility's established technical and quality procedures.

Improve Coordination Between Production and Maintenance

Shared equipment information helps production and maintenance teams discuss recurring problems using consistent data.

For example, downtime trends can help maintenance teams prioritise equipment that experiences frequent interruptions, while production teams can coordinate schedules around planned maintenance activities.

Support Continuous Improvement

Historical OEE data helps managers assess whether operational changes are producing measurable improvements.

By comparing performance before and after corrective actions, teams can evaluate the effectiveness of maintenance improvements, scheduling changes, and other approved operational initiatives.

OEE Monitoring and Pharmaceutical Compliance

Pharmaceutical manufacturing operates under applicable Good Manufacturing Practice (GMP) requirements and other regulatory controls depending on the product, market, and manufacturing facility.

OEE monitoring is an operational performance tool. It should complement, not replace, the systems and procedures used to maintain product quality and regulatory compliance.

When implementing monitoring software, manufacturers should consider the following areas.

Data Integrity and Traceability

Production information should be collected, handled, and reviewed according to the organisation's applicable data-integrity requirements.

Where monitoring data forms part of regulated records or is used to support regulated decisions, appropriate controls may be required for accuracy, traceability, access, and record retention.

System Validation and Intended Use

Before using software in a regulated process, manufacturers should determine its intended use and assess the validation requirements applicable to that use.

A system used only for operational visibility may have different requirements from one used to create, modify, or maintain regulated electronic records.

The validation approach should be determined by the organisation's quality and regulatory teams.

Access Control and Change Management

Access permissions should be appropriate to each user's responsibilities.

Changes to system configurations, production parameters, and calculation rules should follow the organisation's established change-control procedures where applicable.

Separation of Operational Monitoring and Quality Release

An OEE dashboard can help identify production losses, but it should not be treated as an independent product-quality approval or batch-release system.

Quality decisions must remain within the facility's approved quality-management processes.

These considerations help manufacturers use production monitoring responsibly while maintaining the controls required for pharmaceutical operations.

Implementing OEE Monitoring in a Pharmaceutical Manufacturing Plant

Successful implementation requires an understanding of the equipment, production processes, machine connectivity, and intended use of the monitoring data.

Step 1: Identify Equipment and Production Areas

Start by documenting the equipment that needs to be monitored.

This may include:

• Granulation equipment

• Drying systems

• Tablet compression machines

• Coating machines

• Capsule filling machines

• Liquid filling equipment

• Packaging machines

• Inspection systems

Record machine identification, controller type, available signals, production units, and monitoring requirements.

Step 2: Define OEE Calculation Rules

Establish consistent rules for calculating equipment effectiveness.

Define:

• Planned production time

• Shift schedules

• Reference production rates

• Production units

• Total output

• Good and rejected output

• Downtime categories

• Planned cleaning and changeover treatment

Different pharmaceutical processes require different reference values and production units.

These rules should be reviewed by the relevant operations and quality stakeholders before implementation.

Step 3: Connect Equipment to the Monitoring System

Machine information may be collected through supported controller interfaces, PLC signals, sensors, or other suitable integration methods.

The appropriate approach depends on equipment manufacturer, machine age, controller capabilities, and available signals.

All connected signals should be tested to ensure that machine status and production events are interpreted correctly.

If the monitoring solution is intended to interact with regulated systems or records, the integration and validation requirements should be assessed before deployment.

Step 4: Configure Machine-Level and Production Dashboards

Configure dashboards according to the needs of operators, supervisors, and operations managers.

Machine-level views can help identify equipment-specific interruptions, while production-level dashboards provide a consolidated view of performance across manufacturing areas.

Keep operational monitoring information distinct from regulated records unless the system has been appropriately assessed and configured for that intended use.

Step 5: Train Users

Operators, supervisors, maintenance teams, and managers should understand how machine status, production counts, and downtime reasons are recorded and interpreted.

Training should also explain the limitations of OEE data and the procedures for reporting inaccurate or incomplete information.

Step 6: Validate and Expand

Start with selected equipment or one production area.

Validate machine status, production counts, downtime records, and OEE calculations against actual operating conditions.

Review the monitoring setup with relevant technical and quality stakeholders before expanding it to additional equipment.

Common Challenges in Pharmaceutical OEE Monitoring

Manufacturers should address several practical challenges to ensure that OEE data is accurate and useful.

Different Products Require Different Production Rates

Pharmaceutical products may have different formulations, production requirements, equipment settings, and cycle times.

Using one reference production rate for every product can distort performance calculations.

Maintain appropriate reference values for each relevant product and equipment configuration.

Batch-Based Production Requires Consistent Measurement

Pharmaceutical manufacturing often uses batch-based processes rather than continuous unit production.

Different stages may measure output in kilograms, litres, tablets, capsules, or completed batches.

Define the production unit for each process and ensure that comparisons are meaningful.

Incorrect Downtime Classification

If all machine interruptions are recorded under a single category, it becomes difficult to identify the actual reasons behind production losses.

Create practical downtime categories and ensure that operators understand how to use them consistently.

Planned Cleaning and Changeover Activities

Cleaning, setup, and changeover activities are important parts of pharmaceutical manufacturing.

If these activities are classified inconsistently, OEE comparisons may become misleading.

Define how planned activities and unplanned interruptions will be treated in the calculation model while maintaining the required cleaning and quality procedures.

Incomplete Production and Quality Data

If production output, rejected units, or rework are not recorded consistently, OEE calculations may not represent actual manufacturing performance.

Define clear measurement rules and coordinate data collection with the relevant production and quality teams.

Using OEE Data Without a Review Process

Collecting machine data does not automatically improve equipment performance.

Managers should review significant losses, assign corrective actions, and evaluate the results through the organisation's established operational and quality processes.

How to Choose the Right Pharmaceutical OEE Monitoring Software

Selecting a monitoring solution requires evaluating both technical compatibility and the operational requirements of the pharmaceutical facility.

Consider the following factors:

Equipment compatibility: Check whether the solution can connect with existing manufacturing machines, PLCs, controllers, and sensors.

Real-time machine monitoring: Confirm that the system provides equipment-status information at a frequency suitable for operational decisions.

Automated production counting: Evaluate whether the software can collect the production units required for different manufacturing processes.

Downtime analysis: Check whether machine stoppages can be categorised and analysed by duration and frequency.

Cycle-time monitoring: Ensure that actual production rates can be compared with appropriate product-specific reference values.

Quality information: Review how the system handles good output, rejected units, and rework, while keeping quality decisions within approved procedures.

Dashboard visibility: Confirm that managers can monitor individual equipment and review performance across production areas.

Reporting capabilities: Evaluate support for shift-wise, machine-wise, and historical performance reports.

Integration options: Consider requirements for connecting PLCs, ERP, MES, or other manufacturing systems.

Data governance and validation: Assess whether the solution's intended use, data handling, access controls, and validation approach meet the facility's applicable requirements.

Scalability: Ensure that the solution can support additional equipment and manufacturing areas.

Implementation support: Understand the available assistance for integration, configuration, training, and ongoing technical support.

The right solution should improve operational visibility while fitting the technical, quality, and regulatory environment of the facility.

Measuring the ROI of Pharmaceutical OEE Monitoring

The return on investment from pharmaceutical OEE monitoring depends on how effectively manufacturers use production data to reduce equipment losses and improve operational performance.

Potential benefits include:

• Reduced avoidable equipment downtime

• Improved machine utilisation

• Better production scheduling

• Improved visibility into recurring equipment issues

• More consistent production reporting

• Better coordination between production and maintenance teams

• Improved identification of operational bottlenecks

For example, suppose a packaging machine has 450 minutes of planned production time per shift. Monitoring data identifies recurring interruptions that account for 25 minutes of lost operating time.

If corrective actions recover a portion of that time and the production schedule allows additional output, the manufacturer can estimate the potential value of the improvement.

A realistic ROI assessment should consider software costs, hardware, integration, training, maintenance, and the resources required to sustain improvements.

It should also account for product demand, material availability, quality requirements, and downstream capacity. Recovered machine time does not automatically translate into additional revenue.

Building a Continuous Improvement Process With OEE Data

OEE monitoring should become part of the regular operational improvement process.

Pharmaceutical manufacturers can follow four practical stages:

Measure: Collect reliable equipment-status, production-count, downtime, and quality information.

Analyse: Identify the most significant equipment losses and investigate their underlying causes.

Improve: Implement appropriate corrective actions related to equipment, maintenance, scheduling, or operational processes.

Verify: Compare performance before and after the changes to evaluate whether improvements are sustained.

All changes affecting regulated manufacturing processes should follow the organisation's applicable quality, validation, and change-control procedures.

Regular reviews help operations managers focus on measurable production issues and coordinate improvement activities across production, maintenance, engineering, and quality teams.

Over time, this approach can improve equipment utilisation, strengthen production planning, and support more consistent manufacturing operations.

Conclusion

Pharmaceutical manufacturing depends on reliable equipment, controlled production processes, consistent product quality, and effective coordination across manufacturing operations.

Pharmaceutical OEE Monitoring helps manufacturers measure availability, performance, and quality while providing visibility into equipment downtime, production output, and recurring operational losses.

With accurate machine data, clearly defined OEE calculations, and a structured improvement process, pharma operations managers can identify equipment-related issues, prioritise corrective actions, and make more informed production decisions.

Robato Systems provides production monitoring solutions designed to improve shop-floor visibility and support data-driven manufacturing operations.

Want to improve equipment visibility across your pharmaceutical manufacturing facility? Request a consultation with Robato Systems to discuss your production monitoring requirements.